Redeye: Vitec Q3 2024 - Steady as she goes
Redeye updates its estimates and valuation following Vitec releasing its Q3 2024 report. Top-line figures missed our projections slightly, though margins and organic growth remained solid. With a refilled war chest, we expect the company to deliver continued acquired growth in coming quarters, supplemented with decent margins and organic growth. We make limited changes to our estimates and valuation.
Read more and download the Research Update.
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/